Evidence map›Paper›PMID 41684307›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Designing Scalable Mechano-Virucidal Nanostructured Acrylic Surfaces for Enhanced Viral Inactivation.

Samson W L Mah, Denver P Linklater, Vassil Tzanov, Chaitali Dekiwadia, Sergey Rubanov, Phuc H Le, Laleh Tafakori, Ranya Simons, Graeme Moad, Soichiro Saita and 5 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Samson W L MahSchool of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia.ORCID https://orcid.org/0000-0003-0125-0987
Denver P LinklaterSchool of Science, STEM College, RMIT University, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0003-1433-3685
Vassil TzanovDepartament De Química Física i Inorgànica, Universitat Rovira i Virgili, Tarragona, Spain.ORCID https://orcid.org/0000-0003-4576-0727
Chaitali DekiwadiaRMIT Microscopy and Microanalysis Facility, STEM College, RMIT University, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0002-0928-4420
Sergey RubanovBio21 Institute, Ian Holmes Imaging Centre, The University of Melbourne, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0002-7191-856X
Phuc H LeSchool of Science, STEM College, RMIT University, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0003-2910-7509
Laleh TafakoriSchool of Science, STEM College, RMIT University, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0002-0815-8094
Ranya SimonsCSIRO Manufacturing, Clayton, Victoria, Australia.ORCID https://orcid.org/0000-0003-0560-8106
Graeme MoadCSIRO Manufacturing, Clayton, Victoria, Australia.ORCID https://orcid.org/0000-0002-4375-5580
Soichiro SaitaMitsubishi Chemical Co. Innovation Strategy Division, Chiyoda-ku, Tokyo, Japan.
Takashi YanagishitaDepartment of Applied Chemistry, School of Engineering, Tokyo Metropolitan University, Hachioji, Tokyo, Japan.ORCID https://orcid.org/0000-0002-6079-9294
Hideki MasudaDepartment of Applied Chemistry, School of Engineering, Tokyo Metropolitan University, Hachioji, Tokyo, Japan.ORCID https://orcid.org/0000-0001-7622-1967
Vladimir BaulinDepartament De Química Física i Inorgànica, Universitat Rovira i Virgili, Tarragona, Spain.ORCID https://orcid.org/0000-0002-5956-2601
Natalie A BorgSchool of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia.ORCID https://orcid.org/0000-0002-8677-9056
Elena P IvanovaSchool of Science, STEM College, RMIT University, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0002-5509-8071

Funding

ARC Discovery DP240103271Australian Research Council by the ARC Industrial Transformational Training (ITTC) Centre in Surface Engineering for Advanced Materials (SEAM) IC180100005
6 · The paper itself

Abstract

The transmission of viral pathogens via contaminated surfaces remains a critical public health concern, particularly in shared environments. Conventional antiviral coatings incorporating biocidal compounds face limitations due to cytotoxicity, environmental persistence, degradation, and the risk of promoting antiviral resistance. Nanostructured mechano-bactericidal surfaces have proven effective in preventing bacterial colonization, motivating exploration of their antiviral potential. In this study, flexible nanostructured acrylic films with nanopillar arrays are fabricated using anodized aluminum oxide (AAO) molds and ultraviolet nanoimprint lithography (UV-NIL), providing a scalable mechano-virucidal platform, capable of physically rupturing viral particles. Systematic variation of nanopillar pitch and height reveals that interpillar spacing is the dominant determinant of antiviral efficacy. Dense arrays with a 60 nm pitch reduce human parainfluenza virus type 3 (hPIV-3) infectivity by up to 1.2-log (∼94%) within 1 h. Finite element method (FEM) simulations demonstrate that these arrays generate localized stresses exceeding the estimated ∼10 MPa rupture threshold of the viral envelope. In contrast, increasing the pitch to 100 nm results in diminished antiviral activity that is influenced by nanopillar height, while a 200 nm pitch abolishes antiviral activity. These findings offer a chemical-free, mechano-virucidal strategy for scalable antiviral surface protection across healthcare, consumer, and environmental applications.

Indexed as

Antiviral AgentsNanostructuresVirus InactivationHumansSurface PropertiesAntiviral Agentsantiviral nanostructured surfacesenvironmentally safe materialsmechano‐virucidal effectsnanoimprint lithographypolymersscalable fabricationsurface mechanics

Identifiers

PMID41684307
PMCPMC13104112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.